Cell culture is the practice of growing cells in an artificial environment. This is done to study their behaviors when exposed to the outer environment. There are various ways of cell cultures and each one of them can be used for different purposes depending on their uses. Among these new structures, 3D cell culture has been largely used due to their convenience and alternative uses. It can be described as cells with three-dimensional structures that are clones of tissues and other organs specific architecture. Technological advancements are important to address the growing complexities and challenges and this is where 3D cell culture is benefitted. Due to the emergence of advancements in cell imaging and mapping and analytical systems, cells are increasingly being developed in three dimensions.
According to the Research Report “Global 3D Cell Culture Market (2018-2023)” gives a detailed analysis of the global market for 3D cell culture. The top players in the market are Thermo Fisher Scientific, Corning Inc., Lonza Group, Merck & Co., InSphero AG, and Hamilton, Kuraray, Emulate, Mimetas, Global Cell Solutions Inc. The report provides details about the major challenges impacting market growth. The report contains an in-depth analysis of the vendor’s profile, which includes financial health, business units, key business priorities, SWOT, strategies, and views. The report will help businesses make strategic investment decisions.
3D cell structures are becoming more and more relevant in early drug discovery and efficiency in pharmaceutical research and development. This cell culture is rapidly growing in the health sector due to increase in complexities in cancer research and regenerative medicines. There is immense potential in developing 3D cell cultures for better understanding of tissue maturation, cell differentiation, and organogenesis. They are also being adopted in pharmacies, hospitals, diagnostic centers, and research-oriented corporations mainly because of their research benefits. The only area of concern is about the thickness of 3D cells which is expected to be a deterrent.
Region-wise, North America and Europe dominate the market for 3D cell cultures. This is attributed to the high investment in R&D and health care in the regions. There is also extensive support from the side of the governments that provides for a supportive environment through grants and funds. The emerging market is in the Asia Pacific region. Product – wise, the market can be segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, magnetic levitation, and 3D bioprinting. Based on application and uses, they can be classified into drug discovery and toxicology, cancer and stem cell research, and tissue engineering & regenerative medicine.
To Know More, Click On The Link Below:-
Ankur Gupta, Head Marketing & Communications